BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38564975)

  • 1. Outcomes of atypical (B3) core biopsy lesions diagnosed across BreastScreen NSW, Australia.
    Chou R; Tran D; Descallar J; Jalaludin B; Soon PS
    Breast; 2024 Jun; 75():103720. PubMed ID: 38564975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year Trends in Diagnosis of B3 Breast Lesions and Their Upgrade Rates to Malignant Lesions.
    Griffiths R; Kaur C; Alarcon L; Szollosi Z
    Clin Breast Cancer; 2020 Jun; 20(3):e353-e357. PubMed ID: 32171702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study.
    Rakha E; Beca F; D'Andrea M; Abbas A; Petrou-Nunn W; Shaaban AM; Kandiyil A; Smith S; Menon S; Elsheikh S; ElSayed ME; Lee AH; Sharma N
    J Clin Pathol; 2019 Dec; 72(12):800-804. PubMed ID: 31350292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study.
    Willers N; Neven P; Floris G; Colpaert C; Oldenburger E; Han S; Van Ongeval C; Smeets A; Duhoux FP; Wildiers H; Denolf P; Laudus N; Dequeker E; De Brabander I; Van Damme N; De Schutter H
    Clin Breast Cancer; 2023 Jun; 23(4):e273-e280. PubMed ID: 37085379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B3 lesion upgrade rates in a tertiary Australian breast centre: a 8-year experience (2012-2019).
    Huang YY; Park H; McLaren S; Thirunavukkarasu P; Lin JTW; Rajakaruna R; Dhillon R; Ponniah AK
    ANZ J Surg; 2020 Dec; 90(12):2521-2526. PubMed ID: 32969161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?
    Hennessy G; Boland MR; Bambrick M; Crone L; Lloyd A; Abdelwahab S; Downey E; Staunton M; Hambly N; Mhuircheartaigh NN; Kerr J; Power C; Duke D; Hill AD
    Clin Breast Cancer; 2022 Oct; 22(7):699-704. PubMed ID: 35732544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesions of uncertain malignant potential of the breast (B3) on vacuum-assisted biopsy for microcalcifications: Predictors of malignancy.
    Mariscotti G; Durando M; Ruggirello I; Belli P; Caumo F; Nori J; Zuiani C; Tagliafico A; Bicchierai G; Romanucci G; Londero V; Campanino PP; Bussone R; Castellano I; Mule' A; Caneva A; Bianchi S; Di Loreto C; Bergamasco L; Calabrese M; Fonio P; Houssami N
    Eur J Radiol; 2020 Sep; 130():109194. PubMed ID: 32795765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of vacuum assisted excision in minimising overtreatment of ductal atypias.
    McMahon MA; Haigh I; Chen Y; Millican-Slater RA; Sharma N
    Eur J Radiol; 2020 Oct; 131():109258. PubMed ID: 32919262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk for malignancy.
    Mayer S; Kayser G; Rücker G; Bögner D; Hirschfeld M; Hug C; Stickeler E; Gitsch G; Erbes T
    Breast; 2017 Feb; 31():144-149. PubMed ID: 27866089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features.
    Shiino S; Tsuda H; Yoshida M; Jimbo K; Asaga S; Hojo T; Kinoshita T
    Pathol Int; 2015 Jun; 65(6):293-300. PubMed ID: 25801805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign breast papillomas without atypia diagnosed with core needle biopsy: Outcome of surgical excision and imaging follow-up.
    Polat DS; Knippa EE; Ganti R; Seiler SJ; Goudreau SH
    Eur J Radiol; 2020 Oct; 131():109237. PubMed ID: 32905954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.
    Corbin H; Bomeisl P; Amin AL; Marshall HN; Gilmore H; Harbhajanka A
    Hum Pathol; 2022 Oct; 128():90-100. PubMed ID: 35863513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
    Lucioni M; Rossi C; Lomoro P; Ballati F; Fanizza M; Ferrari A; Garcia-Etienne CA; Boveri E; Meloni G; Sommaruga MG; Ferraris E; Lasagna A; Bonzano E; Paulli M; Sgarella A; Di Giulio G
    Eur Radiol; 2021 Feb; 31(2):920-927. PubMed ID: 32816199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
    Elfgen C; Leo C; Kubik-Huch RA; Muenst S; Schmidt N; Quinn C; McNally S; van Diest PJ; Mann RM; Bago-Horvath Z; Bernathova M; Regitnig P; Fuchsjäger M; Schwegler-Guggemos D; Maranta M; Zehbe S; Tausch C; Güth U; Fallenberg EM; Schrading S; Kothari A; Sonnenschein M; Kampmann G; Kulka J; Tille JC; Körner M; Decker T; Lax SF; Daniaux M; Bjelic-Radisic V; Kacerovsky-Strobl S; Condorelli R; Gnant M; Varga Z
    Virchows Arch; 2023 Jul; 483(1):5-20. PubMed ID: 37330436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the use of vacuum-assisted excisions in the management of B3 breast lesions.
    McLachlan C; Jackson M; Valencia A
    Br J Radiol; 2023 Nov; 96(1151):20230528. PubMed ID: 37750833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upgrade risk of image-targeted radial scar and complex sclerosing lesions diagnosed at needle-guided biopsy: a retrospective study.
    Darras C; Uchida M
    Eur Radiol; 2023 Dec; 33(12):8399-8406. PubMed ID: 37386299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upgrade rate to malignancy of uncertain malignant potential breast lesions (B3 lesions) diagnosed on vacuum-assisted biopsy (VAB) in screen detected microcalcifications: Analysis of 366 cases from a single institution.
    Bianchi S; Caini S; Vezzosi V; Orzalesi L; Piovesan L; Mantellini P; Ambrogetti D
    Eur J Radiol; 2024 Jan; 170():111258. PubMed ID: 38091661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
    Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
    Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of high-risk breast lesions diagnosed using image-guided core needle biopsy: results from a multicenter retrospective study.
    Oktay A; Aslan Ö; Taşkın F; Tunçbilek N; Esen İçten SG; Balcı P; Arıbal ME; Çelik L; Örgüç İŞ; Başaran Demirkazık F; Gültekin S; Aydın AM; Durmaz E; Kul S; Binokay F; Çetin M; Emlik GD; Akpınar MG; Kadıoğlu Voyvoda SN; Polat AV; Başara Akın I; Yıldız Ş; Poyraz N; Özsoy A; Öztekin PS; Elverici E; Bayrak İK; İkizceli T; Dinç F; Sezgin G; Gülşen G; Tunçbilek I; Yalçın SR; Çolakoğlu G; Ağlamış S; Yılmaz R; Rona G; Durhan G; Güner DC; Çelik Yabul F; Günbey Karabekmez L; Tutar B; Göktaş M; Buğdaycı O; Suner A; Özdemirhttps/Orcid Org/ N
    Diagn Interv Radiol; 2023 Jul; 29(4):579-587. PubMed ID: 36994925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign Breast Intraductal Papillomas Without Atypia at Core Needle Biopsies: Is Surgical Excision Necessary?
    Moseley T; Desai B; Whitman GJ; Robinson EK; Saunders T; Gonzalez A; He H
    Ann Surg Oncol; 2021 Mar; 28(3):1347-1355. PubMed ID: 32860176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.